Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0022 | 0.0185 | 0.0286 |
Schistosoma mansoni | tar DNA-binding protein | 0.0219 | 0.233 | 0.2701 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0054 | 0.0533 | 1 |
Echinococcus multilocularis | calcium:calmodulin dependent protein kinase I | 0.0498 | 0.5354 | 0.5333 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0137 | 0.1437 | 1 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0054 | 0.0533 | 0.2985 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0022 | 0.0185 | 1 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0022 | 0.0185 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0009 | 0.0045 | 0.0194 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0123 | 0.1287 | 0.8837 |
Plasmodium falciparum | thioredoxin reductase | 0.0054 | 0.0533 | 1 |
Brugia malayi | MH1 domain containing protein | 0.0009 | 0.0045 | 0.0194 |
Schistosoma mansoni | tar DNA-binding protein | 0.0219 | 0.233 | 0.2701 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.0019 | 0.0148 | 0.0121 |
Loa Loa (eye worm) | glutathione reductase | 0.0054 | 0.0533 | 0.2287 |
Brugia malayi | MH2 domain containing protein | 0.0009 | 0.0045 | 0.0194 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0219 | 0.233 | 1 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0137 | 0.1437 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0498 | 0.5357 | 0.6281 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0022 | 0.0185 | 0.0959 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0054 | 0.0533 | 0.049 |
Brugia malayi | glutathione reductase | 0.0054 | 0.0533 | 0.2287 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0123 | 0.1287 | 0.8837 |
Echinococcus granulosus | calcium:calmodulin dependent protein kinase I | 0.0498 | 0.5354 | 0.6278 |
Brugia malayi | MH2 domain containing protein | 0.0137 | 0.143 | 0.614 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0123 | 0.1287 | 0.8837 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0787 | 0.8502 | 0.8495 |
Leishmania major | trypanothione reductase | 0.0054 | 0.0533 | 1 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0019 | 0.0148 | 0.0635 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0022 | 0.0185 | 0.014 |
Toxoplasma gondii | exonuclease III APE | 0.0022 | 0.0185 | 0.0959 |
Brugia malayi | MH2 domain containing protein | 0.0009 | 0.0045 | 0.0194 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0123 | 0.1287 | 0.8837 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.0019 | 0.0148 | 0.0103 |
Echinococcus granulosus | microtubule associated protein 2 | 0.0787 | 0.8502 | 1 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0022 | 0.0185 | 0.0959 |
Entamoeba histolytica | protein kinase, putative | 0.0498 | 0.5357 | 1 |
Echinococcus granulosus | serine:threonine protein kinase Chk2 | 0.0498 | 0.5357 | 0.6281 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0022 | 0.0185 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0219 | 0.233 | 0.2701 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0137 | 0.1437 | 1 |
Echinococcus multilocularis | serine:threonine protein kinase Chk2 | 0.0498 | 0.5357 | 0.5336 |
Brugia malayi | TAR-binding protein | 0.0219 | 0.233 | 1 |
Plasmodium vivax | glutathione reductase, putative | 0.0054 | 0.0533 | 1 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0137 | 0.1437 | 1 |
Brugia malayi | RNA binding protein | 0.0219 | 0.233 | 1 |
Brugia malayi | alpha keto acid dehydrogenase complex, E3 component, lipoamide dehydrogenase | 0.0014 | 0.0094 | 0.0403 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0022 | 0.0185 | 1 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0123 | 0.1287 | 0.8837 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0022 | 0.0185 | 0.0959 |
Mycobacterium tuberculosis | Probable reductase | 0.0123 | 0.1287 | 0.8837 |
Brugia malayi | Smad1 | 0.0009 | 0.0045 | 0.0194 |
Loa Loa (eye worm) | RNA binding protein | 0.0219 | 0.233 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0137 | 0.143 | 0.614 |
Loa Loa (eye worm) | Smad1 | 0.0009 | 0.0045 | 0.0194 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0022 | 0.0185 | 1 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.0019 | 0.0148 | 0.0121 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0019 | 0.0148 | 0.5 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0054 | 0.0533 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0219 | 0.233 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0219 | 0.233 | 0.2295 |
Toxoplasma gondii | thioredoxin reductase | 0.0054 | 0.0533 | 1 |
Schistosoma mansoni | ap endonuclease | 0.0022 | 0.0185 | 0.0165 |
Schistosoma mansoni | tar DNA-binding protein | 0.0219 | 0.233 | 0.2701 |
Trypanosoma brucei | trypanothione reductase | 0.0054 | 0.0533 | 1 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0022 | 0.0185 | 0.0794 |
Loa Loa (eye worm) | MH1 domain-containing protein | 0.0009 | 0.0045 | 0.0194 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0022 | 0.0185 | 0.0794 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0022 | 0.0185 | 0.0165 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0054 | 0.0533 | 0.0576 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0137 | 0.143 | 0.614 |
Brugia malayi | Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain containing protein | 0.0014 | 0.0094 | 0.0403 |
Brugia malayi | Thioredoxin reductase | 0.0054 | 0.0533 | 0.2287 |
Echinococcus granulosus | tar DNA binding protein | 0.0219 | 0.233 | 0.2701 |
Schistosoma mansoni | tar DNA-binding protein | 0.0219 | 0.233 | 0.2701 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0022 | 0.0185 | 0.0959 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0787 | 0.8502 | 1 |
Plasmodium falciparum | glutathione reductase | 0.0054 | 0.0533 | 1 |
Brugia malayi | MH1 domain containing protein | 0.0009 | 0.0045 | 0.0194 |
Entamoeba histolytica | protein kinase, putative | 0.0498 | 0.5357 | 1 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0022 | 0.0185 | 1 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0022 | 0.0185 | 0.0959 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0054 | 0.0533 | 0.2287 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0022 | 0.0185 | 0.0959 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0219 | 0.233 | 1 |
Schistosoma mansoni | ap endonuclease | 0.0022 | 0.0185 | 0.0165 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | Inhibition of Homo sapiens (human) recombinant cyclooxygenase-2 assessed as formation of PGF2a at 200 uM by enzyme immunoassay | ChEMBL. | No reference | |
Inhibition (binding) | = 16 % | Inhibition of Ovis aries (sheep) COX1 assessed as formation of PGF2a at 200 uM by enzyme immunoassay | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.